跳至主要内容
临床试验/NCT06010121
NCT06010121已完成不适用

Comparison of Bioavailability of Liposomal and Traditional Formulation of Vitamin D3

AronPharma Sp. z o. o.2 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2023年2月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
27
试验地点
2
主要终点
Level of 25-hydroxycholecalciferol

研究概览

简要总结

The aim of the study was to compare the profiles of 25-hydroxyvitamin D serum concentration in healthy adults after 4 weeks of using vitamin D supplementation either in a liposomal or a traditional formulation.

详细描述

The study will be randomized, cross-over, participants will be randomly assigned to one of the study groups: A) the group receiving vitamin D3 in traditional formulation B) the group receiving vitamin D3 in liposomal formulation. The day before the start of supplementation (T0), 2 weeks (T1) and 4 weeks (T2) after the start of supplementation, participants will have their blood drawn. Then, after a wash-out period of 2 months, the groups will be switched. Participants will again receive daily supplementation with vitamin D3 for 4 weeks. Blood will be drawn before the start of supplementation (T0), 2 weeks (T1) and 4 weeks (T2) after the start of supplementation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Women and men, 18-60 years old.
  • Signed informed consent.
  • No injuries or hospitalizations within the last 3 months.
  • No vitamin D supplementation for the 2 months prior to the study initiation.
  • Refraining for the period of the clinical trial from consuming foods additionally fortified with vitamin D and dietary supplements containing vitamin D
  • Refraining for the period of the clinical trial from the use of cosmetic therapies that use prolonged body illumination

排除标准

  • Unwilling to give consent
  • Injuries within the last 3 months
  • Obesity, BMI above 30
  • Bariatric surgery
  • Cystic fibrosis, celiac disease, Crohn's disease
  • Metabolic diseases
  • Drugs reducing cholesterol absorption, thiazide diuretics, glucocorticosteroids, anticonvulsants, calcium-containing preparations,
  • Planned prolonged exposure to sunlight during the study period

结局指标

主要结局

Level of 25-hydroxycholecalciferol

时间窗: Baseline, 2 weeks, 4 weeks

Comparison of the level of 25(OH)D3 achieved in the blood

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验